The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Life Line aims to offer Lucent's blood-based testing through its mobile delivery model at urban and rural community health screening events.

Last week, readers were most interested in a story about the conviction of lab owner, formerly an NFL player, for genetic testing fraud.